Publications by authors named "Gejing Deng"

Claim this Profile
A
Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.
Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Gejing Deng

Transfusion· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.
Edward Seung, Zhen Xing, Lan Wu, Ercole Rao, Virna Cortez-Retamozo, Gejing Deng

Nature· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.
Edward Seung, Zhen Xing, Lan Wu, Ercole Rao, Virna Cortez-Retamozo, Gejing Deng

Nature· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation.
Lan Wu, Edward Seung, Ling Xu, Ercole Rao, Dana M Lord, Gejing Deng

Nat Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities.
Jessica McManus, Timothy He, Julie-Ann Gavigan, Ghislaine Marchand, Stephanie Vougier, Gejing Deng

SLAS Discov· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
Ling Xu, Amarendra Pegu, Ercole Rao, Nicole Doria-Rose, Jochen Beninga, Gejing Deng

Science· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Michael Lampa, Heike Arlt, Timothy He, Beatriz Ospina, Jason Reeves, Gejing Deng

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, Shota Tanaka, Franziska Loebel, Gejing Deng

Cancer Cell· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule.
Gejing Deng, Junqing Shen, Ming Yin, Jessica McManus, Magali Mathieu

J Biol Chem· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches.
Qiang Gao, Ingrid Mechin, Nayantara Kothari, Zhuyan Guo, Gejing Deng

J Biol Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of elongation factor G as the conserved cellular target of argyrin B.
Beat Nyfeler, Dominic Hoepfner, Deborah Palestrant, Christina A Kirby, Lewis Whitehead, Gejing Deng

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of LFF571: an investigational agent for Clostridium difficile infection.
Matthew J LaMarche, Jennifer A Leeds, Adam Amaral, Jason T Brewer, Simon M Bushell, Gejing Deng

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time analysis of antibody interactions with whole enveloped human cytomegalovirus using surface plasmon resonance.
Gregg Chenail, Nathan E Brown, Ashley Shea, Adam L Feire, Gejing Deng

Anal Biochem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.
Lac V Lee, Brian Granda, Karl Dean, Jianshi Tao, Eugene Liu, Gejing Deng

Biochemistry· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple cyclophilins involved in different cellular pathways mediate HCV replication.
L Alex Gaither, Jason Borawski, Leah J Anderson, Kara A Balabanis, Piroska Devay, Gejing Deng

Virology· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of mass spectrometry in early stages of target based drug discovery.
Gejing Deng, Gautam Sanyal

J Pharm Biomed Anal· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation.
Fu Shang, Gejing Deng, Qing Liu, Weimin Guo, Arthur L Haas

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an LC-MS based enzyme activity assay for MurC: application to evaluation of inhibitors and kinetic analysis.
Gejing Deng, Rong-Fang Gu, Stephen Marmor, Stewart L Fisher, Haris Jahic

J Pharm Biomed Anal· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis